Medical device and MedTech insights, news, tips and more

Robotics and Virtual Reality Will Dominate These 3 Medical Niches First

September 13, 2017

Virtual Reality

We’re no stranger to robotics in the medical field. Robot-assisted surgery is becoming more and more common. Many training programs are starting to include robotic and virtual reality scenarios to provide hands-on training for students without putting patients at risk.

With all of these advances in medical robotics, three niches stand out above the rest: surgery, medical imaging, and drug discovery. How have robotics already begun to exert their influence on these practices, and how will they change them for good?

Robot-Assisted Surgery

Robot-assisted surgery was first documented in 1985, when it was used for a neurosurgical biopsy. This led to the use of robotics in a number of similar surgeries, both laparoscopic and traditional operations. The FDA didn’t approve robotic surgery tools until 2000, when the da Vinci Surgery system hit the market.

The robot-assisted surgery market is expected to grow steadily into 2023 and potentially beyond. The only thing that might stand in the way of this growth is the cost of the equipment. The initial investment may prevent small practices from purchasing the necessary devices.

Medical Imaging

 Virtual RealityThe key to successful medical imaging isn’t the equipment itself. It’s being able to interpret the information in the images. Medical images are some of the most information-dense pieces of data in the medical field and can reveal so much more than a basic visual inspection can.

Robotics and, more specifically, artificial intelligence programs like IBM Watson can help interpret these images more efficiently and accurately. By allowing an AI or basic machine learning program to study the medical images, researchers can find patterns and make more accurate diagnoses than ever before.

Read More at the Source: Robots and AI Will Take Over These 3 Medical Niches First

More insights

March 7, 2024
FDA Clears Dexcom’s First Over-the-Counter Continuous Glucose Monitor
Learn More
March 1, 2024
FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis
Learn More
February 21, 2024
Sparrow BioAcoustics Launches Software That Turns a Smartphone into a Stethoscope 
Learn More

Begin your legacy now. We are your medtech and medical device talent advisory firm.